disopyramide has been researched along with Recrudescence in 45 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind randomized trial was designed to determine the efficacy of intravenous and oral disopyramide phosphate in preventing neurally mediated syncope induced by a head-up tilt test." | 9.07 | A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. ( Klein, GJ; Leitch, JW; Morillo, CA; Yee, R, 1993) |
| "In order to compare the efficacy in preventing recurrencies of symptomatic atrial fibrillation of amiodarone (A." | 9.07 | [A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation]. ( Locati, F; Nava, S; Veniani, M; Villani, R; Zoletti, F, 1992) |
| "A multi-centre double-blind randomized study is reported in which the effect on mortality of oral disopyramide (300 mg loading dose, then 100 mg qds) was compared with placebo in 1985 patients entering hospital with suspected acute myocardial infarction." | 9.05 | Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group. ( , 1984) |
| "The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia." | 7.67 | [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984) |
| "Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy." | 7.66 | Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983) |
| "The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 6.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
| "A double-blind randomized trial was designed to determine the efficacy of intravenous and oral disopyramide phosphate in preventing neurally mediated syncope induced by a head-up tilt test." | 5.07 | A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. ( Klein, GJ; Leitch, JW; Morillo, CA; Yee, R, 1993) |
| "In order to compare the efficacy in preventing recurrencies of symptomatic atrial fibrillation of amiodarone (A." | 5.07 | [A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation]. ( Locati, F; Nava, S; Veniani, M; Villani, R; Zoletti, F, 1992) |
| "Twenty-five patients with recurrent unexplained syncope and six control subjects were evaluated by use of an upright tilt-table test for 30 minutes, with or without an infusion of isoproterenol (1 to 3 micrograms/minute given intravenously), in an attempt to provoke bradycardia, hypotension, or both." | 5.07 | Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. ( Elliott, L; Grubb, BP; Hahn, H; Temesy-Armos, P, 1991) |
| "The relative safety and efficacy of intravenous administration of adenosine, lignocaine, disopyramide, flecainide, and sotalol for termination of stable, induced ventricular tachycardia was assessed in serial trials." | 5.06 | Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. ( Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE, 1990) |
| "A multi-centre double-blind randomized study is reported in which the effect on mortality of oral disopyramide (300 mg loading dose, then 100 mg qds) was compared with placebo in 1985 patients entering hospital with suspected acute myocardial infarction." | 5.05 | Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group. ( , 1984) |
| "Among the drugs recommended to prevent recurrences of atrial fibrillation after external electric shock, antiarrhythmic agents of classes Ia (quinidine, disopyramide), Ic (cibenzoline, flecainide, propafenone) and III (sotalol) seem to have the same effectiveness in maintaining the sinus rhythm in about 50 percent of the cases after 6 months and one year." | 4.78 | [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock]. ( Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R, 1993) |
| "In order to determine the efficacy of type 1C agents (flecainide, encainide, propafenone) in patients with atrial fibrillation who have failed to maintain sinus rhythm with type 1A agents (quinidine, procainamide, disopyramide), 147 patients, that were admitted into the John Dempsey Hospital with new or recurrent atrial fibrillation between 1987-1991, were studied retrospectively." | 3.68 | Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation. ( Grey, E; Silverman, DI, 1993) |
| "Syncope occurred in nine patients (36%) during the baseline tilt and in seven patients (28%) during isoproterenol infusion (total positives 64%)." | 3.68 | Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. ( Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D, 1992) |
| "The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia." | 3.67 | [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984) |
| "In this study, the safety and efficacy of long-term therapy with disopyramide phosphate were evaluated in 40 patients with documented, recurrent, symptomatic tachyarrhythmias." | 3.67 | Long-term therapy with disopyramide phosphate: side effects and effectiveness. ( Bauernfeind, RA; Bauman, JL; Gallastegui, J; Hoff, J; Strasberg, B; Swiryn, S; Welch, WJ, 1986) |
| " Twenty-six of these patients, who had ventricular fibrillation during single-drug therapy with quinidine, procainamide, or disopyramide, were compared with a control group of 62 patients who had been treated similarly for ventricular arrhythmias but did not have ventricular fibrillation during treatment." | 3.67 | Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. ( Heger, JJ; Miles, WM; Minardo, JD; Prystowsky, EN; Zipes, DP, 1988) |
| "Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy." | 3.66 | Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983) |
| "The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 2.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
| "Atrial flutter is most often arising from a macroreentry circuit in the right atrium or around scar tissue in case or previous cardiothoracic surgery." | 2.43 | [Atrial flutter and fibrillation]. ( Scharf, C, 2005) |
| "A 67-year-old man who had cardiopulmonary arrest (CPA) at home was admitted to our institution." | 1.42 | Early-Morning Type Ventricular Fibrillation With J Wave. ( Fujino, T; Ikeda, T; Tsubota, T; Yamazaki, Y, 2015) |
| "Mexiletine was combined with a conventional type IA antiarrhythmic agent in 25 patients (49%)." | 1.27 | Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. ( Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (51.11) | 18.7374 |
| 1990's | 14 (31.11) | 18.2507 |
| 2000's | 5 (11.11) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perrin, T | 1 |
| Guieu, R | 1 |
| Koutbi, L | 1 |
| Franceschi, F | 1 |
| Hourdain, J | 1 |
| Brignole, M | 1 |
| Deharo, JC | 2 |
| Fujino, T | 1 |
| Yamazaki, Y | 1 |
| Tsubota, T | 1 |
| Ikeda, T | 1 |
| Matsuhashi, T | 1 |
| Sato, T | 1 |
| Aizawa, Y | 1 |
| Takatsuki, S | 1 |
| Shima, Y | 1 |
| Baba, C | 1 |
| Fujita, A | 1 |
| Kanoh, M | 1 |
| Watanabe, M | 1 |
| Ogawa, S | 1 |
| Kawase, R | 1 |
| Shin, S | 1 |
| Eleftheriadis, D | 1 |
| Panagiotis, V | 1 |
| Eleftheriadis, N | 1 |
| Porr, WA | 1 |
| Pernot, C | 1 |
| Jacob, F | 1 |
| Hoeffel, JC | 1 |
| Scharf, C | 1 |
| Palmieri, M | 1 |
| Capucci, A | 1 |
| Lombardi, G | 1 |
| Naccarella, F | 1 |
| Bomba, E | 1 |
| Bracchetti, D | 1 |
| Leone, A | 1 |
| Kasanuki, H | 1 |
| Ohnishi, S | 1 |
| Hirosawa, K | 1 |
| Manz, M | 1 |
| Steinbeck, G | 1 |
| Nitsch, J | 1 |
| Lüderitz, B | 1 |
| Welch, WJ | 2 |
| Strasberg, B | 2 |
| Coelho, A | 1 |
| Rosen, KM | 1 |
| Kito, Y | 1 |
| Ohara, K | 1 |
| Manabe, H | 1 |
| Herling, IM | 1 |
| Horowitz, LN | 2 |
| Josephson, ME | 2 |
| Grey, E | 1 |
| Silverman, DI | 1 |
| Calkins, H | 1 |
| Seifert, M | 1 |
| Morady, F | 1 |
| Morillo, CA | 1 |
| Leitch, JW | 1 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Koenig, A | 1 |
| Theolade, R | 1 |
| Chauvin, M | 1 |
| Brechenmacher, C | 1 |
| Jordaens, L | 1 |
| Missault, L | 1 |
| Germonpré, E | 1 |
| Callens, B | 1 |
| Adang, L | 1 |
| Vandenbogaerde, J | 1 |
| Clement, DL | 1 |
| Sra, JS | 1 |
| Jazayeri, MR | 1 |
| Avitall, B | 1 |
| Dhala, A | 1 |
| Deshpande, S | 1 |
| Blanck, Z | 1 |
| Akhtar, M | 1 |
| Grubb, BP | 3 |
| Kosinski, D | 1 |
| Mouhaffel, A | 1 |
| Pothoulakis, A | 1 |
| Deal, BJ | 1 |
| Strieper, M | 1 |
| Scagliotti, D | 1 |
| Hulse, E | 1 |
| Auld, D | 1 |
| Campbell, R | 1 |
| Strasburger, JF | 1 |
| Benson, DW | 1 |
| Piot, O | 1 |
| Flammang, D | 1 |
| Dambrine, P | 1 |
| Cheikel, J | 1 |
| Jouannon, C | 1 |
| Graux, P | 1 |
| Baudouy, Y | 1 |
| Bine-Scheck, F | 1 |
| Leenhardt, A | 1 |
| Peyre, JP | 1 |
| Chalvidan, T | 1 |
| Thirion, X | 1 |
| Valli, M | 1 |
| Ritter, P | 1 |
| Djiane, P | 1 |
| Benditt, DG | 1 |
| Pritchett, EL | 1 |
| Wallace, AG | 1 |
| Gallagher, JJ | 1 |
| Camm, J | 1 |
| Ward, D | 1 |
| Spurrell, RA | 1 |
| Mason, JW | 1 |
| Winkle, RA | 1 |
| Farshidi, A | 1 |
| Spielman, SR | 1 |
| Michelson, EL | 1 |
| Greenspan, AM | 1 |
| Jutzy, RV | 1 |
| Harner, RH | 1 |
| Boyd, RB | 1 |
| de Lanerolle, TD | 1 |
| Edmunds, V | 1 |
| Wilcox, AH | 1 |
| Wolfe, D | 1 |
| Samoil, D | 1 |
| Madu, E | 1 |
| Temesy-Armos, P | 2 |
| Hahn, H | 2 |
| Elliott, L | 2 |
| Villani, R | 1 |
| Zoletti, F | 1 |
| Veniani, M | 1 |
| Locati, F | 1 |
| Nava, S | 1 |
| Kumagai, K | 1 |
| Yamanouchi, Y | 1 |
| Hiroki, T | 1 |
| Arakawa, K | 1 |
| Griffith, MJ | 1 |
| Linker, NJ | 1 |
| Garratt, CJ | 1 |
| Ward, DE | 1 |
| Camm, AJ | 1 |
| Bauman, JL | 1 |
| Gallastegui, J | 1 |
| Swiryn, S | 1 |
| Hoff, J | 1 |
| Bauernfeind, RA | 1 |
| Minardo, JD | 1 |
| Heger, JJ | 1 |
| Miles, WM | 1 |
| Zipes, DP | 1 |
| Prystowsky, EN | 1 |
| Nakazawa, HK | 1 |
| Handa, S | 1 |
| Nakamura, Y | 1 |
| Oyanagi, H | 1 |
| Hasegawa, M | 1 |
| Ishikawa, N | 1 |
| Ozaki, O | 1 |
| Ito, K | 1 |
| Poole, JE | 1 |
| Werner, JA | 1 |
| Bardy, GH | 1 |
| Graham, EL | 1 |
| Pulaski, WP | 1 |
| Fahrenbruch, CE | 1 |
| Greene, HL | 1 |
| Kushakovskiĭ, MS | 1 |
| Uzilevskaia, RA | 1 |
| Härtel, G | 1 |
| Louhija, A | 1 |
| Konttinen, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306] | 150 participants (Anticipated) | Interventional | 2013-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for disopyramide and Recrudescence
| Article | Year |
|---|---|
[Idiopathic dilatation of the right atrium manifested in infancy by arrhythmia].
Topics: Acetyldigoxins; Angiocardiography; Anti-Arrhythmia Agents; Cardiac Catheterization; Child; Dilatatio | 1976 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia | 2005 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; El | 1993 |
10 trials available for disopyramide and Recrudescence
| Article | Year |
|---|---|
Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group.
Topics: Clinical Trials as Topic; Disopyramide; Double-Blind Method; Female; Hospitalization; Humans; Male; | 1984 |
A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.
Topics: Administration, Oral; Adult; Disopyramide; Double-Blind Method; Female; Follow-Up Studies; Humans; I | 1993 |
Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion.
Topics: Adult; Aged; Aged, 80 and over; Atrial Flutter; Atrial Function; Blood Flow Velocity; Cardiac Output | 1993 |
[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Double-Blind Method; Female; Humans | 1998 |
Clinical studies of Norpace (Part IV).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as T | 1975 |
[A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation].
Topics: Amiodarone; Analysis of Variance; Atrial Fibrillation; Delayed-Action Preparations; Disopyramide; Fo | 1992 |
Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Disopyramide; Female; Human | 1991 |
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramid | 1990 |
[Trial of the clinical use of Ritmilen].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1985 |
Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Disopyramide; El | 1974 |
32 other studies available for disopyramide and Recrudescence
| Article | Year |
|---|---|
Theophylline as an adjunct to control malignant ventricular arrhythmia associated with early repolarization.
Topics: Anti-Arrhythmia Agents; Child; Defibrillators, Implantable; Disopyramide; Humans; Male; Quinidine; R | 2018 |
Early-Morning Type Ventricular Fibrillation With J Wave.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Defibrillators, Implantable; Disopyrami | 2015 |
Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.
Topics: Aged; Anti-Arrhythmia Agents; Disopyramide; Female; Heart Arrest; Humans; Hypothermia, Induced; Long | 2010 |
Simultaneous supraventricular tachycardias in both fetuses of a twin gestation.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Drug Therapy, Combinatio | 2004 |
Recurrent syncopic episodes as a consequence of combined Brugada syndrome and paroxysmal atrial fibrillation. Which is the therapy of choice?
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Disopyramide; Female; Humans | 2004 |
Is this form of syncope to blame?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Disopyramide; Humans; Medical History Taking; N | 2004 |
[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Topics: Anti-Arrhythmia Agents; Disopyramide; Drug Evaluation; Heart Ventricles; Humans; Propafenone; Propio | 1984 |
[Use of intravenous disopyramide in the treatment of symptomatic refractory ventricular arrhythmia].
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Heart Ventricles; Humans; | 1984 |
Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrocardiogr | 1983 |
Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged | 1983 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procaina | 1982 |
[Postoperative treatment of acquired valvular disease with atrial fibrillation with disopyramide--with special reference to prevention of recurrence of atrial fibrillation].
Topics: Adult; Atrial Fibrillation; Disopyramide; Heart Valve Diseases; Humans; Middle Aged; Premedication; | 1982 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe | 1980 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Hear | 1993 |
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; E | 1995 |
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Topics: Adolescent; Adult; Aged; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Female; Follow-Up St | 1993 |
The use of methylphenidate in the treatment of refractory neurocardiogenic syncope.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Bradycardia; Central Nervous S | 1996 |
The medical therapy of cardioinhibitory syncope in pediatric patients.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Child; Cohort Studies; Disopy | 1997 |
Continuous monitoring of an endocardial index of myocardial contractility during head-up tilt test.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiotonic Agents; Disopyramide; Dobutamine; E | 2000 |
Disopyramide in myocardial infarction.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Humans; Middle Aged; Myocardial Infarctio | 1977 |
Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
Topics: Administration, Oral; Adult; Aged; Disopyramide; Electric Stimulation; Female; Follow-Up Studies; He | 1979 |
The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
Topics: Atrial Fibrillation; Atrial Flutter; Blood Pressure; Disopyramide; Electrocardiography; Humans; Infu | 1979 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 1978 |
Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
Topics: Aged; Disopyramide; Electric Countershock; Heart Aneurysm; Humans; Male; Myocardial Infarction; Prop | 1977 |
Disopyramide in a case of recurrent ventricular fibrillation.
Topics: Aged; Disopyramide; Humans; Lidocaine; Male; Pyridines; Recurrence; Ventricular Fibrillation | 1976 |
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; El | 1992 |
Effects of transcatheter cardioversion on chronic lone atrial fibrillation.
Topics: Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Chronic Disease; Disopyram | 1991 |
Long-term therapy with disopyramide phosphate: side effects and effectiveness.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Drug Tolerance; El | 1986 |
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Diuretics; Drug Th | 1988 |
High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.
Topics: Adult; Atrial Fibrillation; Chronic Disease; Disopyramide; Electric Countershock; Electrocardiograph | 1987 |
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophy | 1986 |